Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainPeople with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if bot

Updated on: October 26,2024 0

Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainPeople with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if bot

Updated on:October 26,2024 0

Discoveries detail role of stem cell in deadly gastric cancer

byCornell UniversityKiller T cells surround a cancer cell. Credit: NIHA Cornell study provides important new insights into a common and deadly type of gastric cancer.Incidence of this cancer, ca

Updated on: December 22,2023 23

Discoveries detail role of stem cell in deadly gastric cancer

byCornell UniversityKiller T cells surround a cancer cell. Credit: NIHA Cornell study provides important new insights into a common and deadly type of gastric cancer.Incidence of this cancer, ca

Updated on:December 22,2023 23

Gene activation linked to severity of a rare lung cancer

byUniversity of CologneERT expression and telomerase activity in pulmonary carcinoids. Credit:Journal of Clinical Oncology(2024). DOI: 10.1200/JCO.23.02708Pulmonary carcinoids are ra

Updated on: October 24,2024 0

Gene activation linked to severity of a rare lung cancer

byUniversity of CologneERT expression and telomerase activity in pulmonary carcinoids. Credit:Journal of Clinical Oncology(2024). DOI: 10.1200/JCO.23.02708Pulmonary carcinoids are ra

Updated on:October 24,2024 0

Study finds 95 percent satisfaction rate with Mohs surgery

by Patrick McGee,UT Southwestern Medical CenterPatients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with

Updated on: December 20,2023 23

Study finds 95 percent satisfaction rate with Mohs surgery

by Patrick McGee,UT Southwestern Medical CenterPatients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with

Updated on:December 20,2023 23

Stop breaking women's hearts at work: 7 ways to make workplaces better for cardiovascular health

by Shannan M. Grant, Barb Hamilton-Hinch, Dayna Lee-Baggley, Jacquie Gahagan, Jessica Mannette and Leigh-Ann MacFarlane,The ConversationCredit: Unsplash/CC0 Public DomainProminent heart health m

Updated on: March 25,2024 18

Stop breaking women's hearts at work: 7 ways to make workplaces better for cardiovascular health

by Shannan M. Grant, Barb Hamilton-Hinch, Dayna Lee-Baggley, Jacquie Gahagan, Jessica Mannette and Leigh-Ann MacFarlane,The ConversationCredit: Unsplash/CC0 Public DomainProminent heart health m

Updated on:March 25,2024 18

Robotic resection cuts perioperative morbidity with liver cancer

by Lori SolomonRobotic liver resection (RLR) is associated with a significant reduction in perioperative morbidity for treatment of hepatocellular carcinoma (HCC) versus open-liver resection (OLR), ac

Updated on: December 25,2023 9

Robotic resection cuts perioperative morbidity with liver cancer

by Lori SolomonRobotic liver resection (RLR) is associated with a significant reduction in perioperative morbidity for treatment of hepatocellular carcinoma (HCC) versus open-liver resection (OLR), ac

Updated on:December 25,2023 9

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on: December 20,2023 18

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on:December 20,2023 18

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the

Updated on: December 22,2023 11

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the

Updated on:December 22,2023 11

Customizing T cell-based immunotherapies using new 'SNAPtag' technology

byUniversity of PittsburghUniversal adaptor SNAP-CAR and SNAP-synNotch receptor function. a A benzylguanine motif (BG) is chemically conjugated to an antibody using a benzylguanine NHS ester. Th

Updated on: January 04,2024 12

Customizing T cell-based immunotherapies using new 'SNAPtag' technology

byUniversity of PittsburghUniversal adaptor SNAP-CAR and SNAP-synNotch receptor function. a A benzylguanine motif (BG) is chemically conjugated to an antibody using a benzylguanine NHS ester. Th

Updated on:January 04,2024 12

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present

Updated on: May 05,2024 17

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present

Updated on:May 05,2024 17

Fourth SARS-CoV-2 vaccination also protects cancer patients

by Johannes Angerer,Medical University of ViennaReceptor-Binding Domain and Angiotensin-Converting Enzyme 2 Interaction Inhibition in Patients With Hematologic Malignant Neoplasm With or Without

Updated on: December 20,2023 10

Fourth SARS-CoV-2 vaccination also protects cancer patients

by Johannes Angerer,Medical University of ViennaReceptor-Binding Domain and Angiotensin-Converting Enzyme 2 Interaction Inhibition in Patients With Hematologic Malignant Neoplasm With or Without

Updated on:December 20,2023 10

Transistors help identify cancer cell markers

by Tokyo Medical and Dental UniversityIon-sensitive field effect transistors detect breast cancer cells expressing EGFR when bound by an antibody linked to a chemical reporter. Credit: Department of B

Updated on: December 26,2023 12

Transistors help identify cancer cell markers

by Tokyo Medical and Dental UniversityIon-sensitive field effect transistors detect breast cancer cells expressing EGFR when bound by an antibody linked to a chemical reporter. Credit: Department of B

Updated on:December 26,2023 12